VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $237,000 | +82.3% | 28,400 | +176.2% | 0.10% | +218.8% |
| Q2 2015 | $130,000 | -16.7% | 10,281 | -5.7% | 0.03% | -38.5% |
| Q4 2014 | $156,000 | -40.7% | 10,900 | -32.7% | 0.05% | -32.5% |
| Q1 2014 | $263,000 | +39.2% | 16,200 | +6.6% | 0.08% | +14.9% |
| Q4 2013 | $189,000 | -80.1% | 15,200 | -87.1% | 0.07% | -63.0% |
| Q2 2013 | $949,000 | – | 117,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |